Consensus Eli Lilly and Company Borsa Italiana

Equities

4LLY

US5324571083

Real-time Estimate Tradegate Other stock markets 09:56:17 17/07/2024 pm IST			5-day change	1st Jan Change
840.8 ^EUR	-3.79%		+2.14%	+66.00%

06:24pm	Global markets live: Adidas, TSMC, Vale, HSBC, J&J...
03:53pm	TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	MT

Evolution of the average Target Price on Eli Lilly and Company

Price target over the last 5 years

History of analyst recommendation changes

eaffe114634cf6f5c37e1646a925.eyZ_jUCPwsApwdN1v_LOMBKBF3wUs5agx0sq2EGWz1w.NGQ5oC_ZpJ96lpg6_peoYlrJVBBbw-OYqDFY9Xek_yYvcinLNsGH-XqW4w~9a3390bf49e87804d080a4368cd0e481

Analyst Recommendations on Eli Lilly and Company

TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850	07:23pm	MT
ANALYST RECOMMENDATIONS : American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly...	02:41pm
Goldman Sachs Adjusts Price Target on Eli Lilly to $812 From $793	16/07	MT
UBS Raises Price Target on Eli Lilly to $1,100 From $910, Maintains Buy Rating	12/07	MT
JPMorgan Adjusts Price Target on Eli Lilly and Co. to $1,000 From $900, Maintains Overweight Rating	11/07	MT
Morgan Stanley Adjusts Price Target on Eli Lilly and Co. to $1,083 From $1,023, Maintains Overweight Rating	11/07	MT
Berenberg Adjusts Price Target on Eli Lilly & Co. to $1,000 From $850, Maintains Buy Rating	11/07	MT
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices	11/07	RE
Barclays Adjusts Price Target on Eli Lilly to $1,025 From $913	10/07	MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Wednesday; Tesla to Advance, Reddit to Decline	03/07	MT
Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating	03/07	MT
Jefferies Adjusts Price Target on Eli Lilly & Co. to $1,041 From $1,015, Maintains Buy Rating	03/07	MT
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices	03/07	MT
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	02/07	MT
Biden says Novo Nordisk must cut prices of diabetes, weight loss drugs	02/07	RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say in USA Today Op-Ed	02/07	MT
Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Tesla to Advance, Nvidia to Decline	01/07	MT
ANALYST RECOMMENDATIONS : Capri Holdings, Adobe, Broadcom, Celanese, Admiral...	25/06
Truist Adjusts Price Target on Eli Lilly & Co. to $1,000 From $892 After Model Update, Maintains Buy Rating	25/06	MT
Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update	24/06	DJ
Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994	24/06	MT
BIOGEN EXEC SAYS THE ALZHEIMER'S DRUG MARKET "WILL DEVELOP FASTE…	12/06	RE
Social Buzz: Wallstreetbets Stocks Mixed Premarket Wednesday; Oracle to Advance, AST SpaceMobile to Open Lower	12/06	MT
Jefferies Adjusts Price Target on Eli Lilly and Co. to $994 From $957	11/06	MT
Jefferies Adjusts Price Target on Eli Lilly to $957 From $925	07/06	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

941.6 USD

Average target price

901.5 USD

Spread / Average Target

-4.26%

High Price Target

1,100 USD

Spread / Highest target

+16.82%

Low Price Target

540 USD

Spread / Lowest Target

-42.65%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eli Lilly and Company

Jefferies & Co.
Goldman Sachs
Argus
Redburn Atlantic
China International Capital
JPMorgan Chase
Wolfe Research
Barclays
BMO Capital
Leerink Partners
Deutsche Bank Securities
Truist Securities
Wells Fargo Securities
Morgan Stanley
UBS
BofA Securities
DZ Bank
JEFFERIES	Akash Tewari
Cantor Fitzgerald
Morningstar
Guggenheim
Daiwa Securities
Berenberg Bank
Citigroup
Credit Suisse
HSBC
TD Cowen
SVB Securities LLC
Cowen
Mizuho Securities

Ratings for Eli Lilly and Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar